NEW YORK (GenomeWeb News) - As new DNA-sequencing technologies enter the market, vendors and users are seeking applications other than whole-genome sequencing and even emerging ones such as mRNA-expression profiling.
They might not have to look far.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.